Moreover, it is likely that the effects observed in HCC may be generalized to other highly glycolytic cancers as high PARP14 expression was also found in glioblastoma, breast, gastric and lung cancers, and knocking down PARP14 impaired aerobic glycolysis in human cell lines derived from these cancers. Here, PARP14 is linked to cancer.